TAKE profit and loss

Latest FY26

Revenue: ₹54.2crNo figure a year before
EBITDA: −₹1.9cr−₹7.5 cr in FY25
Net profit: ₹10.8cr−71.0% on FY25
EPS: ₹0.74−71.1% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	84.6	54.2	0.0	65.6	189	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	8.0	6.7	10.2	1.6	8.4
	92.5	60.9	10.2	67.2	198
	0.0	0.0	0.0	24.4	83.0
	84.5	54.2	0.0	0.0	0.0
	0.4	0.4	1.1	15.0	47.9
	0.2	0.3	2.0	5.4	7.5
	0.0	0.0	0.0	7.9	16.8
	1.5	1.5	6.4	39.7	77.2
	86.5	56.5	9.5	92.4	232
	−1.7	−1.9	−7.5	−13.5	−19.0
	−1.7	−1.9	−7.5	−21.3	−35.9
Profit
	6.1	4.4	0.7	−25.2	−34.9
	0.0	0.0	0.0	−93.2	−10.4
	6.1	4.4	0.7	−118	−45.3
	0.2	0.0	0.0	0.7	3.2
	0.0	0.2	0.0	0.5	−1.5
	0.2	0.2	0.0	1.2	1.7
	12.8	10.8	37.5	−120	−100
	5.9	4.3	0.7	−120	−47.0
	6.9	6.6	36.7	0.0	−53.4
	0.1	0.0	−0.0	−0.0	3.1
	12.9	10.9	37.4	−120	−97.2
	—	—	37.5	−120	−100
	—	—	0.0	0.0	−0.1
Per share
	₹0.86	₹0.74	₹2.56	−₹8.18	−₹6.86
	₹0.86	₹0.74	₹2.56	−₹8.18	−₹6.86
Continuing & discontinued operations
	6.9	6.6	36.7	0.0	−53.4
	0.0	0.0	−0.0	0.0	0.0
Other comprehensive income — detail
	—	0.0	−0.0	—	—
	—	—	0.1	−0.0	4.1
	—	—	—	−0.0	1.4
	—	—	−0.1	0.0	0.5
	—	−0.0	0.0	—	—
	—	—	37.4	−0.0	−97.1
	—	—	0.0	−120	−0.1
Per share — as-filed variants
	₹0.39	₹0.29	₹0.05	−₹8.18	−₹3.21
	₹0.39	₹0.29	₹0.05	−₹8.18	−₹3.21
	₹0.47	₹0.45	₹2.51	₹0.00	−₹3.65
	₹0.47	₹0.45	₹2.51	₹0.00	−₹3.65
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	0.1	−0.0	—	41.2	106
	0.1%	−0.0%	—	62.7%	56.1%
Adjusted (ex-exceptional items) — derived
	6.1	4.4	0.7	−25.2	−34.9
	0.0	0.0	0.0	−93.2	−10.4
	12.8	10.8	37.5	−26.4	−90.0
	₹0.86	₹0.74	₹2.56	−₹1.81	−₹6.15

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

TAKE₹10.93

TAKE Limited

· Pharma & Health

Annual Quarterly₹ CrorePeersVIMTALABS SUVENMcap ₹162 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	189.1	65.6	0.0	54.2	84.6
Other Income	8.4	1.6	10.2	6.7	8.0
Total Income	197.5	67.2	10.2	60.9	92.5
Expenses
+ Cost of Materials Consumed	83.0	24.4	0.0	0.0	0.0
+ Purchases of Stock-in-Trade	0.0	0.0	0.0	54.2	84.5
+ Employee Benefit Expense	47.9	15.0	1.1	0.4	0.4
+ Finance Costs	7.5	5.4	2.0	0.3	0.2
+ Depreciation & Amortisation	16.8	7.9	0.0	0.0	0.0
+ Other Expenses	77.2	39.7	6.4	1.5	1.5
Total Expenses	232.4	92.4	9.5	56.5	86.5
EBITDA	-19.0	-13.5	-7.5	-1.9	-1.7
EBIT	-35.9	-21.3	-7.5	-1.9	-1.7
Profit
PBT before Exceptional Items	-34.9	-25.2	0.7	4.4	6.1
+ Exceptional Items	-10.4	-93.2	0.0	0.0	0.0
Pretax Income	-45.3	-118.4	0.7	4.4	6.1
+ Current Tax	3.2	0.7	0.0	0.0	0.2
+ Deferred Tax	-1.5	0.5	0.0	0.2	0.0
Tax Expense	1.7	1.2	0.0	0.2	0.2
Net Income	-100.4	-119.6	37.5	10.8	12.8
+ Net Income — Continuing Ops	-47.0	-119.6	0.7	4.3	5.9
+ Net Income — Discontinued Ops	-53.4	0.0	36.7	6.6	6.9
+ Other Comprehensive Income	3.1	-0.0	-0.0	0.0	0.1
Total Comprehensive Income	-97.2	-119.6	37.4	10.9	12.9
Net Income to Common	-100.3	-119.6	37.5	—	—
Minority Interest	-0.1	0.0	0.0	—	—
Per Share
Basic EPS	-6.86	-8.18	2.56	0.74	0.86
Diluted EPS	-6.86	-8.18	2.56	0.74	0.86
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	-53.4	0.0	36.7	6.6	6.9
+ Tax — Discontinued Operations	0.0	0.0	-0.0	0.0	0.0
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-0.0	0.0	—
+ Items NOT to be Reclassified to P&L	4.1	-0.0	0.1	—	—
+ Tax on Items NOT to be Reclassified — alt tag	1.4	-0.0	—	—	—
+ Items to be Reclassified to P&L	0.5	0.0	-0.1	—	—
+ Tax on Items to be Reclassified	—	—	0.0	-0.0	—
Comprehensive Income — Owners of Parent	-97.1	-0.0	37.4	—	—
Comprehensive Income — Non-controlling Interests	-0.1	-119.6	0.0	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	-3.21	-8.18	0.05	0.29	0.39
Diluted EPS — Continuing Operations	-3.21	-8.18	0.05	0.29	0.39
Basic EPS — Discontinued Operations	-3.65	0.00	2.51	0.45	0.47
Diluted EPS — Discontinued Operations	-3.65	0.00	2.51	0.45	0.47
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	106.1	41.2	—	-0.0	0.1
Gross Margin %	56.10	62.75	—	-0.03	0.11
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	-34.9	-25.2	0.7	4.4	6.1
− Exceptional Items (reconciliation)	-10.4	-93.2	0.0	0.0	0.0
Net Income Adj (tax-effected)	-90.0	-26.4	37.5	10.8	12.8
EPS Adj	-6.15	-1.81	2.56	0.74	0.86
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00	1.00
Paid Up Equity Capital	14.6	14.6	14.6	14.8	14.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.